Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

Hasbro is a leading toy and game company whose mission is to entertain and connect generations of fans through the wonder of storytelling and exhilaration of play. Hasbro delivers engaging brand experiences for global audiences through toys, consumer products, gaming and entertainment, with a portfolio of iconic brands including MAGIC: THE GATHERING, DUNGEONS & DRAGONS, Hasbro Gaming, NERF, TRANSFORMERS, PLAY-DOH and PEPPA PIG, as well as premier partner brands.

Artificial intelligence, augmented reality, Internet of Things – these are not just trends, they are drivers changing the way people live across the globe. With these new drivers and the increasing speed of innovation, there comes an expectation for higher-quality, higher-performing technologies at a faster pace. Every day, and for more than 50 years, Entegris’ singular mission has been to help customers utilize our advanced science-based solutions to support demand drivers; to innovate faster and more efficiently; and ultimately to transform the world. Through the power of our solutions and technology expertise, Entegris provides customers with innovative, science-based solutions to their toughest technology challenges. Headquartered in Billerica, Massachusetts, Entegris employs approximately 8,000 people worldwide, with roughly half employed in Asia-Pacific or Europe. With research and development, customer service, analytical labs, and manufacturing in Asia-Pacific, North America and Europe, Entegris supports customers around the globe as they take technology to the next level.

Cabot Corporation (NYSE: CBT) is a leading global specialty chemical and performance materials company headquartered in Boston, Massachusetts. We deliver performance solutions that solve customers'​ challenges today and prepare them to meet tomorrow's needs.

Parent company CCL Industries employs over 26,00 people and operates more than 214 production facilities in 43 countries with corporate offices in Toronto, Canada, and Framingham, Massachusetts. CCL Label is the world's largest converter of pressure sensitive and extruded film materials for a wide range of decorative, instructional and functional applications for large global customers in the consumer packaging, agricultural, healthcare, automotive and consumer durables markets. Extruded plastic tubes, folded instructional leaflets, precision printed & die cut metal components with LED displays and other complementary products and services are sold in parallel to specific end-use markets. Our Mission and Vision To be the global supply chain leader of innovative label solutions for the world’s largest corporations in the consumer packaging, consumer durable and healthcare markets. Markets Food & Dairy Beauty & Personal Care Home Care & Laundry Ag & Specialty Chemical Beverage Wine & Spirits Specialty Products Healthcare Promotions Tubes Automotive & Durables Security

Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in psychiatry and neurology, oncology, urology, women’s health, rare disease, and cell and gene therapies. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc. and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company. Community Guidelines: https://www.us.sumitomo-pharma.com/social-media/index.html

At Toray Plastics (America), Inc., we dream big, work hard, and believe in possibilities. Like our parent company, the Toray Group, we aim to contribute to society through the creation of new value with innovative ideas, technologies, and products and are dedicated to environmental, social, and corporate governance. For more than thirty years, our products have been specified by a variety of customers to make a wide range of finished goods for consumer and industrial applications. There’s an excellent chance you come into contact with a product made with a Toray material every day. TPA’s headquarters in North Kingstown, Rhode Island, is home to the Torayfan® and Lumirror® Films divisions. The PEF Foam Division is located in Front Royal, Virginia. Visionary leadership, state-of-the-art facilities, and employees’ dedication to teamwork, innovation, and customer service have enabled the company to become a global leader in the markets it serves. Toray team members embody the collaborative spirit and are energetic, creative problem-solvers. The company hires personnel in a variety of specialties, including engineering, maintenance, production, sales, accounting, human resources, and customer service.

Sappi is a leading global provider of powerful everyday materials made from woodfibre-based renewable resources. Together with our partners, we are moving quickly toward a more circular economy. Sappi works to build a thriving world by acting boldly to support the planet, people and prosperity. Our products are manufactured from woodfibre sourced from sustainably-managed forests and plantations, in production facilities powered, in many cases, with bio-energy from steam and existing waste streams and many of our operations are energy self-sufficient. Our products include raw material offerings (such as dissolving pulp (DP), wood pulp and biomaterials as well as end-use products (packaging and speciality papers, graphic papers, casting and release papers and forestry products). Sappi has over 12,800 employees in over 35 countries and manufacturing operations on three continents (ten production facilities in Western Europe, four in North America and five in Southern Africa) which produce approximately: 5.7 million tons per year of paper 2.4 million tons per year of paper pulp, and 1.4 million tons per year of dissolving pulp. Our market-leading range of products is sold and distributed to our direct and indirect customer base across more than 150 countries. Learn more about us on our website.

Celebrating 100 Years of People, Partners, and Products! Founded in 1924 and privately held, we are a material science company that is celebrating its 100-year success because of the hard work, dedication and partnership with its people, customers and suppliers. All across the world, people come into contact with products and meaningful experiences that our materials are part of. At Teknor, that’s a major reason why we love what we do. Serving seven industries and a century of expertise, we have the capability and problem-solving determination to deliver highly tailored custom and sustainable solutions. As a global leader in the material science industry, we’ve always ventured beyond the boundaries of traditional thinking, providing our employees with the freedom for innovative and strategic thought. With 10 U.S. locations plus global operations in Belgium, Germany, Singapore, and China; we provide an atmosphere that stimulates and develops our diverse workforce in an effort to bring together the best ideas and talent across the business!

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For information on our Community Guidelines, please visit sarepta.com/community-guidelines. We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud

In 1965, Robert Kraft graduated from the Harvard Business School and began laying the foundation for starting companies based on working with customers in a highly personalized way. Every one of the Kraft Group's businesses has since inherited the goal of creating value for every customer in an up close and personal way. Today, we do business in over 80 countries with 5,000+ employees delivering exemplary service to our customers. The Kraft Group is a holding company with the network and capital resources of a large global corporation, our interests are diverse and concentrated in five specific areas: •Paper/packaging manufacturing and forest products distribution •Sports & entertainment •Real estate development •Private equity investing •Philanthropy